Erik Harris - EVP & Chief Commercial Officer at Ultragenyx Pharmaceutical Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- EVP & Chief Commercial Officer
- Issuer Symbol
- RARE on Nasdaq
- All Insider Reports
- All Insider Reports
Erik Harris - trading volume in the past year for Ultragenyx Pharmaceutical Inc.
| Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|
| Buys | ||||
| Sells | -10,539 | 100% | $22.80 | -$240,289 |
| Net | -10,539 | -100% | -$240,289 |
Holdings reported by Erik Harris for Ultragenyx Pharmaceutical Inc.
| Security | Num Shares | Value | Price $ | Transaction Date | Ownership | Underlying Class | Underlying Amount |
|---|---|---|---|---|---|---|---|
| Common Stock | 118,410 | $2,480,689 | $20.95 | 16 Apr 2026 | Direct | ||
| Stock Option (Right to Buy) | 49,960 | 16 Apr 2026 | Direct | Common Stock |
Transactions reported by Erik Harris for Ultragenyx Pharmaceutical Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.